News

Podcast

EyePod: Modifier Gene Therapy: What is it?

In this episode of EyePod, David Hutton sits down with Neena Haider, PhD, and Arun Upadhyay, PhD, to talk about modifier gene therapy.

In this episode of EyePod, David Hutton sits down with Neena Haider, PhD, and Arun Upadhyay, PhD, to talk about modifier gene therapy.

Related Videos
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
Jay Barth, MD
Moving beyond the drop: CEO provides updates on Oyster Point's pipeline
Stargardt research: Therapy on the horizon for inherited retinal disease
Related Content
eyeDNA Therapeutics receives FDA Rare Pediatric Disease Designation for HORA-PDE6b, a novel gene therapy for PDE6b retinitis pigmentosa
December 17th 2024

eyeDNA Therapeutics receives FDA Rare Pediatric Disease Designation for HORA-PDE6b, a novel gene therapy for PDE6b retinitis pigmentosa

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
August 30th 2024

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

Researchers awarded $2.7 million NIH grant to study retinal connections in RP
December 14th 2024

Researchers awarded $2.7 million NIH grant to study retinal connections in RP

Eyepod: Ocugen CEO gives update on OCU400
October 2nd 2023

Eyepod: Ocugen CEO gives update on OCU400

Nona Biosciences and Kodiak Sciences partner to develop novel antibodies for ophthalmic diseases
December 10th 2024

Nona Biosciences and Kodiak Sciences partner to develop novel antibodies for ophthalmic diseases

mRNA therapy shows promise for treating proliferative vitreoretinopathy
November 29th 2024

mRNA therapy shows promise for treating proliferative vitreoretinopathy

© 2024 MJH Life Sciences

All rights reserved.